456
Views
13
CrossRef citations to date
0
Altmetric
Drug Evaluations

Varenicline for tobacco dependence: panacea or plight?

, MD, , MD MPH FACP, , PhD, , MBBS MPH, , BDS MPH & , PhD
Pages 1799-1812 | Published online: 06 Jun 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

JillM. Williams. (2012) Varenicline Should Be Used as a First-Line Treatment to Help Smokers With Mental Illness Quit. Journal of Dual Diagnosis 8:2, pages 113-116.
Read now

Articles from other publishers (12)

Andrew L. Pipe & Robert D. Reid. (2018) Smoking Cessation and Cardiac Rehabilitation: A Priority!. Canadian Journal of Cardiology 34:10, pages S247-S251.
Crossref
Drishti Shah, Anuj Shah, Xi Tan & Usha Sambamoorthi. (2017) Trends in utilization of smoking cessation agents before and after the passage of FDA boxed warning in the United States. Drug and Alcohol Dependence 177, pages 187-193.
Crossref
Natalia Obsada & Jadwiga Zalewska-Kaszubska. (2016) Wareniklina – częściowy agonista receptorów nikotynowych w terapii zespołu uzależnienia od alkoholu. Alcoholism and Drug Addiction 29:2, pages 93-101.
Crossref
John R. Hughes. (2015) Varenicline as a Cause of Suicidal Outcomes. Nicotine & Tobacco Research, pages ntu275.
Crossref
Clare L. Ross & Trevor T. Hansel. (2014) New Drug Therapies for COPD. Clinics in Chest Medicine 35:1, pages 219-239.
Crossref
Shiroh Kishioka, Norikazu Kiguchi, Yuka Kobayashi & Fumihiro Saika. (2014) Nicotine Effects and the Endogenous Opioid System. Journal of Pharmacological Sciences 125:2, pages 117-124.
Crossref
Keiko Ueno, Norikazu Kiguchi, Yuka Kobayashi, Fumihiro Saika, Naoki Wakida, Chizuko Yamamoto, Takehiko Maeda, Masanobu Ozaki & Shiroh Kishioka. (2014) Possible Involvement of Endogenous Opioid System Located Downstream of α7 Nicotinic Acetylcholine Receptor in Mice With Physical Dependence on Nicotine. Journal of Pharmacological Sciences 124:1, pages 47-53.
Crossref
Lilia Zurkovsky, Warren D. Taylor & Paul A. Newhouse. (2013) Cognition as a therapeutic target in late-life depression: Potential for nicotinic therapeutics. Biochemical Pharmacology 86:8, pages 1133-1144.
Crossref
Emily M. Jutkiewicz, Kenner C. Rice, F. Ivy Carroll & James H. Woods. (2013) Patterns of nicotinic receptor antagonism II: Cardiovascular effects in rats. Drug and Alcohol Dependence 131:3, pages 284-297.
Crossref
Roel JT Mocking, C Patrick Pflanz, Abbie Pringle, Elizabeth Parsons, Sarah F McTavish, Phil J Cowen & Catherine J Harmer. (2012) Effects of Short-Term Varenicline Administration on Emotional and Cognitive Processing in Healthy, Non-Smoking Adults: A Randomized, Double-Blind, Study. Neuropsychopharmacology 38:3, pages 476-484.
Crossref
Tanuja Bordia, Maya Hrachova, Matthew Chin, J. Michael McIntosh & Maryka Quik. (2012) Varenicline Is a Potent Partial Agonist at α6β2* Nicotinic Acetylcholine Receptors in Rat and Monkey Striatum. Journal of Pharmacology and Experimental Therapeutics 342:2, pages 327-334.
Crossref
David C.L. Lam & John D. Minna. (2011) How Do We Safely Get People to Stop Smoking?. Cancer Prevention Research 4:11, pages 1724-1727.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.